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Summary: A non-denaturing polyacrylamide gel electrophoresis procedure is described for the analysis of
isoforms of human red blood cell glyoxalase II (EC 3.1.2.6). A cathodic, continuous buffer electrophoresis
system was developed, using a 60 g/1 polyacrylamide gel with 25 g/1 N^-methylene-bis-acrylamide in
50 mmol/1 sodium succinate buffer, pH 5.5 and 1 °C. Staining for glyoxalase II activity involved
(a) washing the gel with 50 mmol/1 Tris-HCl buffer, pH 7.4 and 37 °C, and
(b) incubation with developing agent (0.5 g/1 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide,
0.1 g/1 2,6-dichlorophenolindophenol, 1 mmol/1 S-Z)-lactoylglutathione in 100 mmol/1 Tris-HCl, pH 7.4).
Two activity bands were found in all human blood samples studied to date, probably reflecting the presence
of two major isoforms. Optimal sample storage and preparation procedures and validation studies are
described. This method is currently in use in an ongoing investigation of glyoxalase II isoforms in disease
processes.
Introduction
Glyoxalase II (hydroxyacylglutathione hydrolase)2)
catalyses the hydrolysis of S-/)-lactoylglutathione to
reduced glutathione and ZMactate (1).
MeCH(OH)CO-SG Glyoxalase II
+ H20 *
MeCH(OH)CO2H
+ GSH
Human red blood cell glyoxalase II is a monomeric
protein of relative molecular mass Mr 21 000. Two
forms of glyoxalase II with pi values of 8.09 and 8.40
have been resolved by chromatofocussing (2). Glyox-
alase II is present in the cytosol of all cells. It is a
*) Funding organisation:
The Wellcome Trust
2) Enzymes:
γ-Glutamyltransferase, [5-glutamyl]-peptide: amino-acid 5-
glutamyltransferase, EC 2.3.2.2;
Glyoxalase I, S-lactoyl-glutathione methylglyoxal-lyase [iso-
merising], EC 4.4.1.5;
Glyoxalase II, S-2-hydroxyacylglutathione hydrolase, EC
3.1.2.6.
component of the glyoxalase system which catalyses
the conversion of methylglyoxal to D-lactate via the
intermediate S-Z)-lactoylglutathione (3).
The gene for human glyoxalase II, HAGH, has been
localised to chromosome band 16pl3.3. The 16pl3
band represents about half of the short arm of chro-
mosome 16. The genetic locus for phosphoglycolate
phosphatase is also present in this band (4 — 6). Ge-
netic polymorphism of glyoxalase II is extremely rare,
and only one phenotype (HAGH1) is usually ex-
pressed. However, a rare second form, HAGH2, has
been found in Micronesian (7) and Japanese (8) pop-
ulations. The population genetics of human glyoxal-
ases have recently been reviewed (9).
Electrophoretic analysis of glyoxalase II phenotypes
is usually performed using an anodic starch gel elec-
trophoresis method. HAGH1 is electrophoretically
"slow" and HAGH2 "fast" (8, 9). However, the two
isoforms of distinctive isoelectric point are not re-
solved. Uotila (1979) resolved the isoforms of glyox-
alase II by chromatofocussing (2).
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In this report, we describe a non-denaturing poly-
acrylamide gel electrophoresis procedure for analysis
of glyoxalase II isoforms. This method is currently
being used to screen of glyoxalase II isoforms in
diabetic patients.
Materials and Methods
Acrylamide, N^'-methylene-bis-acrylamide and Ν,Ν,Ν',Ν1-
tetramethyl-ethylenediamine were electrophoresis grade re-
agents purchased from Sigma Chem. Co., Poole, Dorset, U. K.
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide,
2,6-dichlorophenol-indophenol, basic fuchsin, acivicin and all
other reagents were of analytical grade from Sigma. S-D-Lac-
toylglutathione was synthesised enzymatically using glyoxalase
I2) and purified by ion exchange chromatography (10).
Sample p repa ra t ion
Whole blood samples, drawn by venipuncture with sodium
ethylenediaminetetra-acetate anticoagulant, were treated with
4 volumes of ice-cold distilled water. The sample was centri-
fuged (9000 g, 10 min) and an aliquot of the supernatant (150
μΐ) was added to 350 μΐ of electrophoresis sample buffer (140
g/1 sucrose, 0.3 g/1 basic fuchsin and 30.5 mmol/1 succinate
buffer, pH 5.5, at 1 °C in water — see below).
Po lyac ry l amide gel e lec t rophores is
Non-denaturing polyacrylamide electrophoresis was performed
on a vertical cathodic continuous polyacrylamide gel (140
χ 180 χ 1.5 mm). The gel was prepared with a total concen-
tration of 60 g/1 acrylamide and a concentration of 26 g/1 Ν,Ν1-
methylene-bis-acrylamide in 50 mmol/1 succinic acid/sodium
succinate, pH 5.5, with 3.1 mmol/1 ammonium persulphate and
0.46 g/1 N,N,N\NMetramethylethylenediamine. Electrophore-
sis was performed in an electrode buffer consisting of 50 mmol/1
succinate buffer, pH 5.5, at 1 CC.
The gels were pre-electrophoresed at 50V for 15 min. The
protein sample (30 μΐ) was absorbed onto the gel by applying
a constant voltage of 50 V for 30 min. The electrophoresis was
continued for a further 6 hours at a constant of 200 V.
S t a i n i n g for g lyoxa la se I I a c t i v i t y
After electrophoresis the gel was washed with 100 mmol/1 Tris-
HC1 buffer, pH 7.4, at 37 °C. It was then incubated in devel-
oping reagent (0.5 g/1 3-[4,5-dimethylthiazol-2-yl]-2,5-diphen-
yltetrazolium bromide, 0.1 g/1 2,6-dichlorophenolindophenol,
1 mmol/1 S-Z)-lactoylglutathione in 100 mmol/1 Tris-HCl, pH
7.4) at 37 CC until the dark purple/blue bands associated with
glyoxalase II activity became clearly discernable. The gel was
fixed by immersion in 1.22 mol/1 acetic acid in distilled water.
Appa ra tu s
Polyacrylamide electrophoresis gels were cast in a Pharmacia
(Pharmacia LKB Biotechnology, Uppsala, Sweden) GSC-2
casting stand. Electrophoresis was performed with a Pharmacia
GE 2/4 vertical electrophoresis system with a Pharmacia ECPS
3000/150 power supply.
Fig. 1.
Θ
Non-denaturing polyacrylamide gel electrophoresis of
human red blood cell glyoxalase II
Electrophoresis: The gel was prepared, electrophoresed
and stained as described in the Materials and Methods
section.
Lanes 1 and 2 are replicates from washed red blood
cells; lanes 3 and 4 are replicates from whole blood
samples.
Assignment:
A. glyoxalase II positive stain (isoform S),
B. glyoxalase II positive stain (isoform F),
C. haemoglobin band.
Results and Discussion
Glyoxalase II activity is present in the cytosol of
human blood cells: platelets, leukocytes and red blood
cells (11 — 13). The glyoxalase II activity in whole
blood lysates mainly (> 99%) originates from lysed
red blood cells.
Non-denaturing polyacrylamide gel electrophoresis of
whole blood cell lysate, stained for activity of glyox-
alase II is shown in figure 1. There is a red band
present in the gel before staining, associated with
haemoglobin. Bands of glyoxalase II activity stain
appeared between the anode and the haemoglobin
and during staining with the developing agent. One
band, the one furthest from the anode with the greater
electrophoretic mobility (isoform F), was consistently
stained more intensely than the other band (isoform
S). The development of these bands required the pres-
ence of S-Z)-lactoylglutathione, 3-[4,5-dimethylthia-
zol-2-yl]-2,5-diphenyltetrazolium bromide and 2,6-
dichlorophenolindophenol. The same bands also ap-
peared when other substrates of glyoxalase II were
substituted for S-Z)-lactoylglutathione: S-glycolylglu-
tathione, S-L-glyceroylglutathione and S-D-mande-
lylglutathione were all tried and proved positive (data
not shown).
To bands of glyoxalase II activity were resolved in all
human blood samples studied and samples of isolated
red blood cells. Incubation of protein samples with
the γ-glutamyltransferase2) inhibitor, acivicin (200
μηιοΐ/l), did not change the glyoxalase activity pattern
or its intensity.
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Optimum blood sample processing for electrophoretic
analysis of glyoxalase II isoforms was found for whole
blood samples diluted with electrophoresis buffer im-
mediately prior to electrophoresis, as described in the
Materials and Methods section. Similar results were
also obtained with washed red blood cells (see fig. 1).
Validation studies on blood sample storage tempera-
ture were performed over a 6 week period, storing
blood samples at +4, -20 and -196 °C. Only stor-
age of samples at —196 °C preserved fully the activity
stain of glyoxalase II; at 4 °C, the activity was de-
creased by ca. 80% and at —20 °C the activity was
decreased by ca. 30% after 6 weeks of storage.
Glyoxalase II is a thioesterase (1). It is present in the
cytosol of red blood cells as part of the glyoxalase
system (3). Recent interest in the presence of glyox-
alase II activity and isoforms in red blood cells of
clinical blood samples has arisen from the correlation
of characteristic activities of red blood cell glyoxalase
II with the development of clinical complications as-
sociated with diabetes mellitus (14). It is not known
whether this activity correlation is associated with
different isoforms in complicated and uncomplicated
diabetic patients, or whether it is due to other factors.
A correlation with isoforms may be investigated by
screening red blood cell glyoxalase II by a non-den-
aturing electrophoretic procedure. To screen diabetic
patients for isoforms of glyoxalase II an improved
polyacrylamide gel electrophoresis method was re-
quired.
Previously reported electrophoresis methods for the
analysis of phenotypes of glyoxalase II used a starch
gel procedure, e. g. (7). A polyacrylamide gel system
is preferred because of the variability in quality of
starch. We have described herein a cathodic contin-
uous polyacrylamide gel electrophoresis procedure for
analysis of glyoxalase II isoforms.
There is usually only one phenotype of glyoxalase II
in human red blood cells (7, 8, 15). However, two
isoforms with isoelectric points of 8.09 and 8.40 are
thought to be present (2). The use of anodic poly-
acrylamide gel electrophoresis to resolve these iso-
forms using buffers of pH values higher than 8.40,
was excluded since glyoxalase II has poor activity
stability in this pH range and the substrate S-Z>-
lactoylglutathione hydrolyses spontaneously at high
pH (unpublished observation), thereby interfering
with the staining procedure. Since human red blood
cell glyoxalase II has good stability at pH values of
5 — 8, a cathodic polyacrylamide gel electrophoresis
procedure was developed. Uotila (2) has reported an
acetate-buffered cathodic polyacrylamide gel electro-
phoresis procedure for analysis of human red blood
cell glyoxalase II but obtained a large smear of activity
stain overlapping into the haemoglobin band. This
was reproducible in our hands. The method described
here gave much better resolution, with sharper, dis-
crete bands.
Staining for glyoxalase II activity is mediated by the
formation of reduced glutathione. At the loci of glyox-
alase II activity, S-D-lactoylglutathione is converted
to reduced glutathione. This reduces 3-[4,5-dimethyl-
thiazol-2-yl]-2,5-diphenyltetrazolium bromide, via the
electron transfer mediator 2,6-dichlorophenol-indo-
phenol, to produce the dark-blue/purple formazan-
type stain. No staining was obtained in the absence
of S-£>-lactoylglutathione or glyoxalase II activity,
consistent with the specificity of the stained bands for
glyoxalase II.
A reactive thiol could conceivably be formed by the
action of γ-glutamyltransferase on S-£Mactoylgluta-
thione (16). Although γ-glutamyltransferase is consid-
ered to be absent from red blood cells, it is thought
to be present in plasma and other blood cells (17).
Incubation of protein samples with the irreversible
inhibitor of γ-glutamyltransferase acivicin (17) had
no effect on the staining pattern, indicating that γ-
glutamyltransferase activity did not significantly com-
promise the glyoxalase II activity stain.
The interpretation of the two bands of glyoxalase II
activity is probably best described as indicative of two
isoforms since, from previous reports (7, 8, 15), we
do not expect there to be two phenotypes in the blood
samples of Caucasian origin studied, although une-
quivocal discrimination between isoforms and phen-
otypes of glyoxalase will be possible only when gene
hybridisation probes become available. The presence
of two isoforms is in keeping with the chromatofo-
cussing results of Uotila (2). The electrophoretic mo-
bility of isoforms in polyacrylamide gel electropho-
resis is influenced by distinctive charge density, mo-
lecular shape and size characteristics of the proteins.
The distinctive isoelectric points of the two isoforms
partially resolved by chromatofocussing may be re-
flected in the two activity bands found in the poly-
acrylamide gel electrophoresis system described
herein.
Isoelectric focussing of human red blood cell glyox-
alase II has been performed by Uotila (2), but it
produced many bands of activity stain. The lack of
agreement between the chromatofocussing and iso-
electric focussing results for glyoxalase II (similar
discordant analysis is found for glyoxalase I) remains
a matter of concern, but it may be due to artifactual
binding of ampholines in isoelectric focussing (18).
The non-denaturing polyacrylamide gel electropho-
resis method described is currently being used to in-
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vestigate the association of isoforms of glyoxalase II
with diabetic complications. This electrophoretic
method gave two activity bands in all donor blood
samples studied to date (n = 12).
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